دورية أكاديمية

HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure

التفاصيل البيبلوغرافية
العنوان: HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure
المؤلفون: Saw Yen Ow, Eugene A. Kapp, Vesna Tomasetig, Anton Zalewski, Jason Simmonds, Con Panousis, Michael J. Wilson, Andrew D. Nash, Matthias Pelzing
المصدر: mAbs, Vol 15, Iss 1 (2023)
بيانات النشر: Taylor & Francis Group, 2023.
سنة النشر: 2023
المجموعة: LCC:Therapeutics. Pharmacology
LCC:Immunologic diseases. Allergy
مصطلحات موضوعية: HDX-MS, binding stoichiometry, epitope mapping, Hageman factor, negative stain electron microscopy, SPR, Therapeutics. Pharmacology, RM1-950, Immunologic diseases. Allergy, RC581-607
الوصف: ABSTRACTHageman factor (FXII) is an essential component in the intrinsic coagulation cascade and a therapeutic target for the prophylactic treatment of hereditary angioedema (HAE). CSL312 (garadacimab) is a novel high-affinity human antibody capable of blocking activated FXII activity that is currently undergoing Phase 3 clinical trials in HAE. Structural studies using hydrogen/deuterium exchange coupled to mass spectrometry revealed evidence of interaction between the antibody and regions surrounding the S1 specificity pocket of FXII, including the 99-loop, 140-loop, 180-loop, and neighboring regions. We propose complementarity-determining regions (CDRs) in heavy-chain CDR2 and CDR3 as potential paratopes on garadacimab, and the 99-loop, 140-loop, 180-loop, and 220-loop as binding sites on the beta chain of activated FXII (β-FXIIa).
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 19420862
1942-0870
1942-0862
Relation: https://doaj.org/toc/1942-0862; https://doaj.org/toc/1942-0870
DOI: 10.1080/19420862.2022.2163459
URL الوصول: https://doaj.org/article/0c07c3f8278b450db8ee8af9dbb53b06
رقم الأكسشن: edsdoj.0c07c3f8278b450db8ee8af9dbb53b06
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:19420862
19420870
DOI:10.1080/19420862.2022.2163459